Simultaneous Targeting of XPO1 and BCL2 as an Effective Treatment Strategy for Double-Hit Lymphoma
Y. Liu, N. Azizian, Y. Dou, L. Pham, Y. Li
This study shows that combining XPO1 and BCL2 inhibitors effectively treats double-hit lymphoma by suppressing MYC and BCL2 oncogenes, reducing tumor growth and preventing metastasis.
bioRxiv · Oct 3, 2019Cancer Biology